Lack of efficacy in treating condyloma acuminata and preventing recurrences with the recombinant quadrivalent
human papillomavirus vaccine in a case series of immunocompetent patients.
vaccines, these brands may prove more popular for children than their parents.
2) At present, the only HPV vaccine licensed for use in males is Gardasil (Merck), a quadrivalent
vaccine which protects against two cancer-causing types of HPV and two that cause genital warts (types 6, 11, 16, 18).
HPA epidemiologist Dr Kate Soldan said: 'A study recently carried out at the HPA demonstrates the considerable impact which genital warts has on health services in England, and suggests a large proportion of this impact could be prevented through immunisation using the quadrivalent
human papillomavirus (HPV) vaccine.
But doctors have suggested that young girls should instead use Gardasil, a quadrivalent
vaccine which prevents both conditions.
now shows the quadrivalent
vaccine to be effective and safe in the age group 25-45 years (Lancet 2009; 373: 1949-1957).
vaccine was the first to be licensed and is available in the US, Europe, Australia and Asia in over 100 countries.
Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent
human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young women, Pediatrics, 2006, 118(5):2135-2145.
The projected drivers of sales growth include the growth of the elderly population and introduction of quadrivalent
seasonal influenza vaccines.
Health care provider education initiatives, including reminding doctors and nurses to take every opportunity to strongly recommend HPV vaccine, especially when they recommend the two other vaccines recommended at age 11 to 12 years (the quadrivalent
meningococcal conjugate and Tdap vaccines) and the annual flu vaccine;
The immunogenicity and efficacy of the recently approved 9-valent human papillomavirus vaccine were similar to those of the currently approved and recommended quadrivalent
HPV vaccine, in an international study of more than 14,000 women.
This new indication for the quadrivalent
HPV vaccine offers for the first time protection from this cancer thanks to a vaccine.